Replimune (REPL) Change in Acquisitions & Divestments (2018 - 2025)
Replimune's (REPL) quarterly Change in Acquisitions & Divestments came in at $101.8 million in Q4 2025, up 10.02% year-on-year from $92.5 million in Q4 2024, and up 6.72% quarter-over-quarter from $95.4 million in Q3 2025.
Replimune (REPL) Change in Acquisitions & Divestments (2018 - 2025) Analysis & Trends
Replimune has disclosed Change in Acquisitions & Divestments across 8 years of filings, most recently posting $101.8 million for Q4 2025.
- Change in Acquisitions & Divestments for Q4 2025 came in at $101.8 million, up 10.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $367.6 million (down 19.17% YoY), and the FY2025 annual result was $386.5 million, down 34.76% from the prior year.
- Change in Acquisitions & Divestments came in at $101.8 million for Q4 2025 at Replimune, up from $95.4 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $177.1 million in Q2 2023 to a low of $41.9 million in Q1 2021.
- The 5-year median for Change in Acquisitions & Divestments is $98.6 million (2025), against an average of $101.1 million.
- Across the five-year window, Change in Acquisitions & Divestments soared 164.39% in 2023 and tumbled 51.2% in 2025, its largest moves.
- Replimune's Change in Acquisitions & Divestments stood at $68.2 million in 2021, then soared by 69.53% to $115.7 million in 2022, then soared by 34.46% to $155.5 million in 2023, then slumped by 40.53% to $92.5 million in 2024, then increased by 10.02% to $101.8 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $101.8 million (Q4 2025), $95.4 million (Q3 2025), and $105.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.77 Mn |
| Dec 31, 2025 | 101.77 Mn |
| Sep 30, 2025 | 95.36 Mn |
| Sep 30, 2025 | 95.36 Mn |
| Jun 30, 2025 | 105.37 Mn |
| Jun 30, 2025 | 105.37 Mn |
| Mar 31, 2025 | 65.07 Mn |
| Mar 31, 2025 | 65.07 Mn |
| Dec 31, 2024 | 92.50 Mn |
| Dec 31, 2024 | 92.50 Mn |
| Sep 30, 2024 | 92.00 Mn |
| Sep 30, 2024 | 92.00 Mn |
| Jun 30, 2024 | 136.91 Mn |
| Jun 30, 2024 | 136.91 Mn |
| Mar 31, 2024 | 133.34 Mn |
| Mar 31, 2024 | 133.34 Mn |
| Dec 31, 2023 | 155.54 Mn |
| Dec 31, 2023 | 155.54 Mn |
| Sep 30, 2023 | 126.35 Mn |
| Sep 30, 2023 | 126.35 Mn |